Benzodiazepines and risk of Alzheimer's disease

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Yaffe, Kristine ^a,b   Scola, Marie ^a,b   Boustani, Malaz ^c,d   Fairbanks, Richard M ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

^d REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ALZHEIMER DISEASE; ANEMIA; ANXIETY DISORDER; CASE CONTROL STUDY; COGNITIVE DEFECT; COHORT ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FOLLOW UP; HUMAN; KIDNEY INJURY; LIFE EXPECTANCY; POLYPHARMACY; PRIORITY JOURNAL; REPRODUCIBILITY; SLEEP DISORDER; STANDARDIZATION; SYSTEMATIC REVIEW (TOPIC); CHEMICALLY INDUCED DISORDER; FEMALE; MALE; NOTE;

ALZHEIMER DISEASE; BENZODIAZEPINES; FEMALE; HUMANS; MALE;

EID: 84988835559     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g5312     Document Type: Editorial

References (9)

1. Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ 2014;349:g5205.
2. Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 2012;29:639-58
3. Koyama A, Steinman M, Ensrud K, Hillier TA, Yaffe K. Ten-year trajectory of potentially inappropriate medications in very old women: importance of cognitive status. J Am Geriatr Soc 2013;61:258-63.
4. Koyama A, Steinman M, Ensrud K, Hillier TA, Yaffe K. Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol Ser A Biol Sci Med Sci 2014;69:423-9.
5. Anderson GF. Chronic care: making the case for ongoing care. Robert Wood Johnson Foundation, 2010.
6. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-9.
7. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
8. Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing 2014; afu096 [epub ahead of print].
9. Boustani M, Baker MS, Campbell N, Munger S, Hui SL, Castelluccio P, et al. Impact and recognition of cognitive impairment among hospitalized elders. J Hosp Med 2010;5:69-75.